Incyte Corp
INCY- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000879169
In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 10 sales; 860 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.
Holders of 5% or more of INCY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Incyte Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.80%15.2M shares | – | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
| State Street Corp | 13G | 5.00%9.68M shares | New | Nov 10, 20251 filing | Nov 10, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Incyte Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20269:53 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 10, 20258:35 AM ET | State Street Corp | 13G | 5.00%9.68M shares | New | Sep 30, 2025 | SEC |
| Oct 17, 20256:13 PM ET | BlackRock, Inc. | 13G/A | 7.80%15.2M shares | – | Sep 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Incyte Corp shares.
No Form 144 notices for Incyte Corp are on file.